St. Jude Medical (STJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 752,000 | 632,000 | 456,000 | 212,000 | 826,000 |
| Depreciation Amortization | 273,000 | 204,000 | 136,000 | 69,000 | 321,000 |
| Income taxes - deferred | -77,000 | -34,000 | -13,000 | -10,000 | -65,000 |
| Accounts receivable | 13,000 | 13,000 | -15,000 | -38,000 | -55,000 |
| Other Working Capital | 227,000 | 24,000 | -49,000 | -50,000 | 56,000 |
| Other Operating Activity | 147,000 | 100,000 | 74,000 | 52,000 | 204,000 |
| Operating Cash Flow | $1,335,000 | $939,000 | $589,000 | $235,000 | $1,287,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -280,000 | -188,000 | -128,000 | -70,000 | -307,000 |
| Sale Of Investment | 19,000 | 19,000 | 12,000 | 6,000 | N/A |
| Other Investing Activity | -52,000 | -28,000 | -25,000 | 1,000 | -30,000 |
| Investing Cash Flow | $-313,000 | $-197,000 | $-141,000 | $-63,000 | $-337,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 321,000 | -272,000 | 174,000 | 211,000 | 247,000 |
| Debt Issued | N/A | 0 | 0 | N/A | 78,000 |
| Debt Repayment | N/A | 0 | 0 | N/A | -78,000 |
| Common Stock Issued | 119,000 | 107,000 | 52,000 | 48,000 | 302,000 |
| Common Stock Repurchased | -992,000 | -300,000 | -300,000 | -300,000 | -809,000 |
| Dividend Paid | -284,000 | -212,000 | -139,000 | -67,000 | -205,000 |
| Other Financing Activity | 23,000 | 0 | 0 | 0 | 9,000 |
| Financing Cash Flow | $-813,000 | $-677,000 | $-213,000 | $-108,000 | $-456,000 |
| Exchange Rate Effect | -1,000 | 0 | -7,000 | 3,000 | -8,000 |
| Beginning Cash Position | 986,000 | 986,000 | 986,000 | 986,000 | 500,000 |
| End Cash Position | 1,194,000 | 1,051,000 | 1,214,000 | 1,053,000 | 986,000 |
| Net Cash Flow | $208,000 | $65,000 | $228,000 | $67,000 | $486,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,335,000 | 939,000 | 589,000 | 235,000 | 1,287,000 |
| Capital Expenditure | -280,000 | -188,000 | -128,000 | -70,000 | -307,000 |
| Free Cash Flow | 1,055,000 | 751,000 | 461,000 | 165,000 | 980,000 |